In a report released yesterday, Joon Lee from Truist Financial downgraded Editas Medicine (EDIT – Research Report) to a Hold, with a price ...

Pick up the right dividend stock, and investors can look forward to high passive income each and every month. The post Buy ...

The oldest and one of the largest Canadian ETFs is an ideal option for long-term investors. The post A Top ETF to Buy With $2 ...

The purchase of Orca Gold in 2022 brought the 70%-owned Meyas Sand gold project in Sudan into its portfolio. While it also acquired Orecorp in fiscal 2024 and intends to develop its 80%-owned Nyanzaga ...

Aradel Holdings Plc, formerly Niger Delta Exploration & Production Company (NDEP), has undergone a remarkable transformation, evolving from a dominant ...

Adobe handily beat Wall Street's targets for its fiscal fourth quarter. But its sales and earnings guidance for 2025 was ...

Block continues to increase its revenue and gross profit. Click here to read more about SQ stock and why it is upgraded to ...

Wes Hughes evaluates top prospects added to 40-man rosters, offering insights on buying or selling each prospect in 2025 ...

In a report released today, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $74.00. Don't Miss our Black Friday ...

Among the deals TradeWinds has not already reported, South Korean owner SK Shipping is said to have raised $68m in total from ...

The stock surged 6% in morning trade, touching a seven-week high of Rs 94.36 per share, driven by fresh product launches and a positive brokerage outlook ... with a 'buy' rating and set a target ...

(NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that its Board of Directors has approved the ...